! ORL via Alexandros G.Sfakianakis on Inoreader: Improved therapeutic effectiveness by combining recombinant p14 with antisense complementary DNA of EGFR in laryngeal squamous cell carcinoma

! ORL via Alexandros G.Sfakianakis on Inoreader

Improved therapeutic effectiveness by combining recombinant p14 with antisense complementary DNA of EGFR in laryngeal squamous cell carcinoma Aug 5th 2015, 01:06, by Feng Liu, JinTao Du, Junming Xian, Yafeng Liu, Shixi Liu, Yan Lin The tumor suppressor p14ARF and proto-oncogene epidermal growth factor receptor (EGFR) play important roles in the development of laryngeal squamous cell carcinoma (LSCC). This study was aimed to determine whether combining recombinant p14ARF with antisense complementary DNA of EGFR could improve the therapeutic effectiveness in LSCC.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions